150 related articles for article (PubMed ID: 23602444)
1. Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors.
Nasrolahi Shirazi A; Tiwari RK; Brown A; Mandal D; Sun G; Parang K
Bioorg Med Chem Lett; 2013 Jun; 23(11):3230-4. PubMed ID: 23602444
[TBL] [Abstract][Full Text] [Related]
2. Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling.
Sanner MF; Zoghebi K; Hanna S; Mozaffari S; Rahighi S; Tiwari RK; Parang K
J Chem Inf Model; 2021 Jun; 61(6):3015-3026. PubMed ID: 34000187
[TBL] [Abstract][Full Text] [Related]
3. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src).
Wang W; Ramdas L; Sun G; Ke S; Obeyesekere NU; Budde RJ; McMurray JS
Biochemistry; 2000 May; 39(17):5221-8. PubMed ID: 10819990
[TBL] [Abstract][Full Text] [Related]
4. Developing and Testing Methylated Nano-Structured Dipeptides that Inhibit Src Kinase Activity In Vitro for Anti-Cancer Applications.
Nahhas AF; Nahhas AF; Webster TJ
J Vis Exp; 2022 Nov; (189):. PubMed ID: 36533825
[TBL] [Abstract][Full Text] [Related]
5. Exquisitely specific bisubstrate inhibitors of c-Src kinase.
Brandvold KR; Santos SM; Breen ME; Lachacz EJ; Steffey ME; Soellner MB
ACS Chem Biol; 2015 Jun; 10(6):1387-91. PubMed ID: 25793938
[TBL] [Abstract][Full Text] [Related]
6. Development of 2'-aminospiro [pyrano[3,2-c]quinoline]-3'-carbonitrile derivatives as non-ATP competitive Src kinase inhibitors that suppress breast cancer cell migration and proliferation.
Ramadan M; A M M Elshaier Y; Aly AA; Abdel-Aziz M; Fathy HM; Brown AB; Pridgen JR; Dalby KN; Kaoud TS
Bioorg Chem; 2021 Nov; 116():105344. PubMed ID: 34598088
[TBL] [Abstract][Full Text] [Related]
7. Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.
Hill ZB; Perera BG; Maly DJ
Mol Biosyst; 2011 Feb; 7(2):447-56. PubMed ID: 21060940
[TBL] [Abstract][Full Text] [Related]
8. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
Johnson TK; Soellner MB
Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
[TBL] [Abstract][Full Text] [Related]
9. Linear and cyclic peptides as substrates for Lyn tyrosine kinase.
Ruzza P; Donella-Deana A; Calderan A; Zanotti G; Cesaro L; Pinna LA; Borin G
J Pept Sci; 1998 Feb; 4(1):33-45. PubMed ID: 9523754
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors.
Li JR; Li DD; Fang F; Du QR; Lin L; Sun J; Qian Y; Zhu HL
Org Biomol Chem; 2013 Dec; 11(48):8375-86. PubMed ID: 24178241
[TBL] [Abstract][Full Text] [Related]
11. Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.
Musumeci F; Fallacara AL; Brullo C; Grossi G; Botta L; Calandro P; Chiariello M; Kissova M; Crespan E; Maga G; Schenone S
Eur J Med Chem; 2017 Feb; 127():369-378. PubMed ID: 28076826
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: the effects of aromatic clusters, D-amino acid substitution and cyclization.
Wessolowski A; Bienert M; Dathe M
J Pept Res; 2004 Oct; 64(4):159-69. PubMed ID: 15357671
[TBL] [Abstract][Full Text] [Related]
13. Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine.
Kwarcinski FE; Fox CC; Steffey ME; Soellner MB
ACS Chem Biol; 2012 Nov; 7(11):1910-7. PubMed ID: 22928736
[TBL] [Abstract][Full Text] [Related]
14. Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles.
Georghiou G; Kleiner RE; Pulkoski-Gross M; Liu DR; Seeliger MA
Nat Chem Biol; 2012 Feb; 8(4):366-74. PubMed ID: 22344177
[TBL] [Abstract][Full Text] [Related]
15. Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma.
Tintori C; Fallacara AL; Radi M; Zamperini C; Dreassi E; Crespan E; Maga G; Schenone S; Musumeci F; Brullo C; Richters A; Gasparrini F; Angelucci A; Festuccia C; Delle Monache S; Rauh D; Botta M
J Med Chem; 2015 Jan; 58(1):347-61. PubMed ID: 25469771
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Evaluation of the Kinase Inhibition Potential of Pyridylpyrimidinylaminophenyl Derivatives.
Manchanda P; Parshad B; Kumar A; Tiwari RK; Shirazi AN; Parang K; Sharma SK
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317151
[TBL] [Abstract][Full Text] [Related]
17. Arginine/Tryptophan-Rich Cyclic α/β-Antimicrobial Peptides: The Roles of Hydrogen Bonding and Hydrophobic/Hydrophilic Solvent-Accessible Surface Areas upon Activity and Membrane Selectivity.
Bagheri M; Amininasab M; Dathe M
Chemistry; 2018 Sep; 24(53):14242-14253. PubMed ID: 29969522
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors.
Tiwari RK; Brown A; Sadeghiani N; Shirazi AN; Bolton J; Tse A; Verkhivker G; Parang K; Sun G
ChemMedChem; 2017 Jan; 12(1):86-99. PubMed ID: 27875633
[TBL] [Abstract][Full Text] [Related]
19. Linear and cyclic synthetic peptides related to the main autophosphorylation site of the Src tyrosine kinases as substrates and inhibitors of Lyn.
Ruzza P; Calderan A; Filippi B; Biondi B; Deana AD; Cesaro L; Pinna LA; Borin G
Int J Pept Protein Res; 1995 Jun; 45(6):529-39. PubMed ID: 7558583
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.
Riahifard N; Mozaffari S; Aldakhil T; Nunez F; Alshammari Q; Alshammari S; Yamaki J; Parang K; Tiwari RK
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
